SCHEMBL7984766

SCHEMBL7984766

Cc1ccc(Cn2cnc3nc(-c4cccnc4)[nH]c(=O)c32)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.44
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
KMT2A Q03164 2/20 0.43
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PNP P00491 1/20 0.42
MAPT P10636 2/20 0.42
KDM4C Q9H3R0 1/20 0.42
KDM4E B2RXH2 1/20 0.41
CNOT7 Q9UIV1 1/20 0.41
KDR P35968 1/20 0.40
EPHB4 P54760 1/20 0.40
DHPS P49366 1/20 0.39
TSHR P16473 1/20 0.39
CLK1 P49759 1/20 0.39
DYRK1A Q13627 1/20 0.39
NPY5R Q15761 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974283 0.90 ALDH1A1 (0.53) HPGDALDH1A1SMN1; SMN2KMT2APNP
SCHEMBL7989418 0.90 SMN1; SMN2 (0.44) HPGDALDH1A1SMN1; SMN2KMT2APNP
SCHEMBL7988931 0.89 GRIN1 (0.44) HPGDALDH1A1SMN1; SMN2KMT2AHSD17B10
SCHEMBL7974236 0.89 ABCC8 (0.43) HPGDALDH1A1SMN1; SMN2KMT2APNP
SCHEMBL7984716 0.88 SMN1; SMN2 (0.53) HPGDALDH1A1SMN1; SMN2KMT2ALMNA
SCHEMBL7985823 0.87 HPGD (0.44) HPGDALDH1A1SMN1; SMN2KMT2ALMNA
SCHEMBL7988656 0.85 NPY5R (0.44) HPGDALDH1A1SMN1; SMN2KMT2AHTT
SCHEMBL7984771 0.83 CNOT7 (0.47) HPGDALDH1A1SMN1; SMN2KMT2ALMNA
SCHEMBL7984419 0.83 SMN1; SMN2 (0.44) HPGDALDH1A1SMN1; SMN2KMT2ALMNA
SCHEMBL7991594 0.83 HPGD (0.44) HPGDALDH1A1SMN1; SMN2KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed